CHRNA4 and Cognitive impairment: Furthermore, we previously observed that oral SAK3 administration potently ameliorated ischemia-induced cognitive impairments and neuronal death by stimulating nAChR-regulated ACh release in the hippocampus of the mouse brain [54].